Comparing Virtual Reality (VR) to Non-VR for Decreasing Preoperative/Procedural Anxiety
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05094141|
Recruitment Status : Recruiting
First Posted : October 26, 2021
Last Update Posted : November 2, 2022
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
The primary objective of the study is to utilize the modified Yale Preoperative Anxiety scale (mYPAS), a validated preoperative/procedural anxiety score, to measure preoperative anxiety via distraction in pediatric oncology patients undergoing port access.
The hypothesis is that using Virtual Reality (VR) will objectively decrease anxiety scores measured by mYPAS by five percent (primary outcome).
The secondary outcome will be the parents or the legally authorized representative (LAR) subjective reports of anxiety with the use of VR.
The Kind VR device is used in house at Children's Health in the Dallas and Plano campuses. The VR device used in this study qualifies as exempt from FDA IDE regulations. It is a non-significant risk, non-invasive, interactive video device the user wears like goggles. The study carries minimal risks to the subjects and is designed to minimize patient discomfort from placement or motion sickness. Furthermore, the device has disposable covers for protection against infection and can be sanitized between uses, once the disposable covers are removed. Children's Health System of Texas (CHST) and this research group are not partnering entities with the Kind VR, and the Kind VR device is not being studied. The effect of virtual reality (VR) on preprocedural anxiety as measured by questionnaires and the observations of the modified Yale Preoperative Anxiety Scale (mYPAS) is being studied
Most patients coming to the Clinic of Cancer and Blood Disorders (CCBD) are under chronic care for their ongoing disease and are likely to be coming to the CCBD at least twice in a 6-month period. The CCBD schedule will be reviewed by the researchers for patients age 5-12, requiring port access at least twice during the next six-month period. Patient families whose child meets the basic screening criteria, and have no exclusion criteria, will be approached privately as possible participants in the study. Up to 100 subjects will be enrolled over a 2-year period. Once the subject/parent or LAR agrees to participate, study staff will randomize the subjects into which standard of care distraction method for anxiety management they will receive first in this study.
|Condition or disease||Intervention/treatment||Phase|
|Preoperative Anxiety||Other: Virtual reality||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||77 participants|
|Intervention Model:||Crossover Assignment|
|Intervention Model Description:||Cross over study will be performed. Subjects will be randomized (1 to 1 randomization) at their initial encounter to either VR or Non-VR. During their second visit patients will be given the alternative mode of care (i.e. patients who initially received VR distraction will be given Non-VR distraction, and patients who initially received Non- VR distraction will receive VR distraction)|
|Official Title:||Randomized Pilot Crossover Study Comparing Virtual Reality (VR) and Non-VR Distraction for Decreasing Preoperative/Procedural Anxiety as a Function of the Modified Yale Preoperative Anxiety Scale (mYPAS)|
|Actual Study Start Date :||January 13, 2021|
|Estimated Primary Completion Date :||December 31, 2023|
|Estimated Study Completion Date :||December 31, 2023|
No Intervention: Non-VR (Virtual reality)
The patient is not assigned to play the VR game. mYPAS scoring for port access is done.
Experimental: VR (Virtual Reality)
The patient is assigned to play the VR game for 15 minutes prior to actual port access procedure start. mYPAS scoring while playing VR device for Port access
Other: Virtual reality
Virtual reality game
- Preoperative anxiety score in pediatric oncology patients [ Time Frame: 2 years ]
Preoperative anxiety score in pediatric oncology patients as measured by modified Yale Preoperative Anxiety Scale (mYPAS), a validated preoperative/procedural anxiety score.
Possible scores range from 23 to 100. Higher score values are correlated with increased preoperative anxiety.
- Number of parents or legally authorized representative (LAR) who subjectively report decreased anxiety with the use of VR [ Time Frame: 2 years ]Number of parents or legally authorized representative (LAR) who subjectively report decreased anxiety with the use of VR (Virtual Reality) would be calculated based on Parents' questionnaires scored and evaluated for subjective improvement in parental assessment of preoperative anxiety.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||5 Years to 12 Years (Child)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||Yes|
- Any patient of the Children's Medical Center CCBD
- 5-12 years of age
- Patient requiring their port accessed twice or more within a 6 months period
- Ability to understand and the willingness to sign a written informed consent.
- Subjects younger than 5 and older than 12
- Patients requiring recovery in PICU or sites other than PACU
- If parents or subject is not willing to participate
- Subjects with severe developmental delays and subjects with developmental challenges preventing them from keeping the VR device on are also excluded
- Patients who will not be in CCBD for port access at least twice in 6 months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05094141
|Contact: Christina Howard||214-456-8559||Christina.Howard@utsouthwestern.edu|
|United States, Texas|
|Dallas, Texas, United States, 75390|
|Contact: Christina Howard 214-456-8559|
|Principal Investigator:||Sarah Rebstock, MD||UT Southwestern|
|Principal Investigator:||Neethu Chandran||UT Southwestern|
|Responsible Party:||Sarah E Rebstock, Associate Professor, University of Texas Southwestern Medical Center|
|Other Study ID Numbers:||
|First Posted:||October 26, 2021 Key Record Dates|
|Last Update Posted:||November 2, 2022|
|Last Verified:||October 2022|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Plan Description:||General information|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|
modified Yale Preoperative Anxiety Scale